Reozalimab Antibody

SKU: orb1944138

Description

Rezilimab is a bispecific antibody that targets PD-1/PD-L1 and mediates antibody-dependent cell cytotoxicity (ADCC) in cancer research.

Research Area

Cell Biology, Immunology & Inflammation

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Recombinant
Target	PD-1/PD-L1
Purity	95.00%
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	5.72 mg/mL
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

PD-1/PD-L1

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols